23 results on '"Ribaudo, Heather J"'
Search Results
2. Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
3. Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk
4. Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms of efavirenz pharmacokinetics and treatment response: an AIDS clinical trials group study
5. Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure
6. Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts
7. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects
8. Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s
9. A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
10. Vitamin D does not Modulate Immune-Mediated Bone loss during ART Initiation
11. Hyperlipidaemia in HIV-Infected Patients on Lopinavir/Ritonavir Monotherapy in Resource-Limited Settings
12. Changes in Plasma Levels of Oxidized Lipoproteins and Lipoprotein Subfractions with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy and Associations with Common Carotid Artery Intima-Media Thickness: ACTG 5260s
13. Differential CD4+cell count increase and CD4+ : CD8+ratio normalization with maraviroc compared with tenofovir
14. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness
15. Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity
16. Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols
17. Cost-Effectiveness Analysis of Ugt1A1Genetic Testing to Inform Antiretroviral Prescribing in HIV Disease
18. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection
19. Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6variants
20. Lopinavirritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
21. Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure
22. Design Issues in Initial HIV-Treatment Trials: Focus on Actg A5095
23. A joint analysis of quality of life and survival using a random effect selection model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.